drkoop buys drDrew to reach teen marketdrkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings
drkoop buys drDrew to reach teen market
drkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings drkoop's user base to some two million, drkoop hopes to drive additional licensing revenue and leverage this access to the teen/young adult audience. While drDrew.com will continue to operate as a separate site, the two sites will integrate some content. The acquisition was not a risky move for the beleaguered dot-com and drkoop will continue to evaluate acquiring "undervalued properties," said Ed Cespedes, president of drkoop.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.